Fractyl Health, Inc. (GUTS) has provided an announcement.
Fractyl Health, Inc. issued a press release on June 24, 2024, providing updates on its clinical studies for weight maintenance and type 2 diabetes treatments. The company also updated its corporate slide presentation to reflect these recent developments, which is available on their investor relations website. This information, although not considered officially filed for regulatory purposes, offers insight into Fractyl’s ongoing research and business progress.
Find detailed analytics on GUTS stock on TipRanks’ Stock Analysis page.
